Alzamend Neuro Quote - ALZN

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.4095

Bid

0.40

Ask

0.4293

Volume

116,573

0.398 Day's Range 0.4299

0.38 52 Week Range 10.6485

Market Cap

2.848M

Previous Close

0.399

Open

0.4189

Last Trade

113

0.4095

(formt)

Last Trade Time

Financial Volume

US$ 47,789

VWAP

0.409947

Average Volume (3m)

83,000

Shares Outstanding

7,120,703

Dividend Yield

PE Ratio

-0.19

Earnings Per Share (EPS)

-2.09

Revenue

Net Profit

-14.88M

Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipe... Alzamend Neuro Inc is an early clinical stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.alzamend.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Alzamend Neuro Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALZN. The last closing price for Alzamend Neuro was US$0.40. Over the last year, Alzamend Neuro shares have traded in a share price range of US$ 0.38 to US$ 10.6485.

Alzamend Neuro currently has 7,120,703 shares outstanding. The market capitalization of Alzamend Neuro is US$2.85 million. Alzamend Neuro has a price to earnings ratio (PE ratio) of -0.19.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1265	-23.6007462687	0.536	0.5669	0.38	304241	0.506823	CS
4	-0.2199	-34.938036225	0.6294	0.63	0.38	97146	0.52424427	CS
12	-0.5705	-58.2142857143	0.98	1.04	0.38	83000	0.61168019	CS
26	-0.5905	-59.05	1	1.29	0.38	68708	0.78811856	CS
52	-9.87	-96.0163432074	10.2795	10.6485	0.38	143902	3.08318292	CS
156	-137.4405	-99.7029379761	137.85	182.1	0.38	1164699	40.78973112	CS
260	-434.5905	-99.905862069	435	503.25	0.38	1166807	41.80859283	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GRCGold Springs Resource Corp	$ 0.09 (20.00%)	255.2k
SFDNXT Energy Solutions Inc	$ 0.16 (18.52%)	118k
SAMStarcore International Mines Ltd	$ 0.14 (16.67%)	525
DSVDiscovery Silver Corp	$ 1.03 (13.19%)	913.48k
PYRPyroGenesis Canada Inc	$ 0.69 (13.11%)	191.75k
CFXCanfor Pulp Products Inc	$ 1.04 (-25.71%)	141.77k
AEZSAeterna Zentaris Inc	$ 6.04 (-24.50%)	14.45k
LPENLoop Energy Inc	$ 0.025 (-16.67%)	15.04k
ETEvertz Technologies Ltd	$ 13.30 (-13.30%)	120.44k
AABAberdeen International Inc	$ 0.035 (-12.50%)	1.61M
CNQCanadian Natural Resources Ltd	$ 47.87 (1.36%)	29.03M
TRPTC Energy Corporation	$ 52.25 (-0.08%)	14.09M
SUSuncor Energy Inc	$ 50.82 (0.08%)	8.95M
MFCManulife Financial Corporation	$ 35.23 (0.46%)	7.75M
POWPower Corp of Canada	$ 37.57 (-0.71%)	6.65M